RheumMadness 2025: The Innovation Invitational

Entry #: 842596 by Gizinskumab

Your correct picks are shown in green and your incorrect picks are shown in red.

Round 1 

CD40L in Sjogren's 

ABA in Pre-RA 

Anifrolumab extension 

TYK2 in SLE 

HCQ Screen Cost 

Pred dose in SLE 

Obinutuzumab in LN 

CD-19 CAR-T 

Round 2 

CD40L in Sjogren's

BiTEs 

Oral anti-IL-23 

TYK2 in SLE

HCQ Screen Cost

SGCAPS 

STRAP Trial 

Obinutuzumab in LN

Round 3 

BiTEs

Oral anti-IL-23

HCQ Screen Cost

Obinutuzumab in LN

Round 4 

Oral anti-IL-23

HCQ Screen Cost

Champion 

Oral anti-IL-23